CILINITAB M 25 Mg : Uses, Dosage, Side Effects, Price, Composition and More.

CILINITAB M 25 Mg

Metoprolol Succinate 23.75 mg & Cilnidipine 10 mg

CILINITAB M 25 is a combination medication used to manage hypertension (high blood pressure) and other cardiovascular conditions. It contains Metoprolol Succinate, a beta-blocker, and Cilnidipine, a calcium channel blocker, which work together to provide comprehensive blood pressure control. This article provides an in-depth look into CILINITAB M 25, covering its uses, dosage, side effects, composition, and more, ensuring a thorough understanding of this medication.

Composition

CILINITAB M 25 contains two active ingredients:

• Metoprolol Succinate: 23.75 mg
• Cilnidipine: 10 mg

Mechanism of Action

Cilnidipine is a calcium channel blocker that inhibits the influx of calcium ions into vascular smooth muscle and cardiac muscle cells. This action causes the blood vessels to relax and dilate, leading to a reduction in blood pressure. Cilnidipine is unique as it blocks both L-type and N-type calcium channels, providing a more comprehensive control of blood pressure.

Uses

CILINITAB M 25 is prescribed for:

• Management of hypertension (high blood pressure)
• Treating angina pectoris (chest pain)
• Managing chronic heart failure

Dosage

The dosage of CILINITAB M 25 should be individualized based on the patient's condition, response to treatment, and medical history. Typically, the recommended starting dose is:

• Metoprolol Succinate: 23.75 mg once daily
• Cilnidipine: 10 mg once daily

Side Effects

Like any medication, CILINITAB M 25 may cause side effects. Common side effects include:

• Fatigue and dizziness
• Headache
• Bradycardia (slow heart rate)
• Flushing or redness of the skin
• Gastrointestinal disturbances (nausea, vomiting, diarrhea)

Serious but rare side effects may include:

• Hypotension (low blood pressure)
• Worsening of heart failure symptoms
• Bronchospasm (narrowing of airways)
• Allergic reactions (rash, itching, swelling)

Precautions

• Heart Conditions: Use with caution in patients with severe bradycardia, heart block, or cardiogenic shock.
• Liver Function: Regular monitoring of liver enzymes is recommended, as Cilnidipine can affect liver function.
• Renal Function: Monitor renal function periodically, especially in patients with pre-existing kidney conditions.
• Hypersensitivity: Avoid use in patients with known hypersensitivity to Metoprolol, Cilnidipine, or any component of the formulation.
• Pregnancy and Lactation: Use with caution during pregnancy and breastfeeding, as the effects on the fetus or infant are not well-studied.

Interactions

CILINITAB M 25 can interact with several medications, potentially altering their effects. Some notable interactions include:

• Other Antihypertensives: Can enhance the blood pressure-lowering effects, increasing the risk of hypotension.
• Antiarrhythmics: May increase the risk of bradycardia and other heart-related side effects.
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Can reduce the antihypertensive effects of CILINITAB M 25.
• Antidiabetic Drugs: Metoprolol can mask the symptoms of hypoglycemia, requiring close monitoring of blood sugar levels.

Monitoring

Regular monitoring is crucial to ensure the safe and effective use of CILINITAB M 25:

• Blood Pressure: Regular monitoring helps assess the efficacy of the medication.
• Heart Rate: Monitor for bradycardia and other heart-related side effects.
• Liver Function: Periodic assessment of liver enzymes is necessary.
• Renal Function: Regular monitoring of kidney function is crucial, especially in patients with pre-existing conditions.

Lifestyle and Dietary Recommendations

• Diet: Follow a balanced diet low in salt and saturated fats. This helps optimize the effects of CILINITAB M 25 and maintain stable blood pressure levels.
• Exercise: Regular physical activity helps improve cardiovascular health. Engage in both aerobic exercises, like walking or swimming, and resistance training.
• Hydration: Maintain adequate fluid intake to support overall health and prevent dehydration.

Conclusion

CILINITAB M 25, combining Metoprolol Succinate and Cilnidipine, offers an effective solution for managing hypertension and other cardiovascular conditions. Always consult with a healthcare provider for personalized advice and monitoring while using this medication. Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW